Khairy Jamaluddin 🇲🇾🌺 on X: "Real world data from Chile has shown significant increase in vaccine effectiveness after a booster for people who took Sinovac for their primary series. Biggest boost came
Measuring Vaccination Impact & Coverage
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
Testing fractional doses of COVID-19 vaccines | PNAS
Effectiveness of COVID-19 booster vaccination strategies in partially vaccinated populations
COVID-19 vaccine breakthrough infections | Science
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron | NEJM
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
BioNTech SE on X: "95.6% relative vaccine efficacy against #Covid19 after a booster shot with our #mRNA vaccine, during a period when Delta was the prevalent strain. These are the first efficacy
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
ATAGI statement on recommendations on a winter booster dose of COVID-19 vaccine | Australian Government Department of Health and Aged Care
Covid booster vaccines effective against severe illness from omicron, CDC says
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 - ScienceDirect
Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario - Ontario COVID-19 Science Advisory Table
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
Vaccines | Free Full-Text | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine | NEJM
Boosting immunity to Omicron | Nature Medicine
After Three Months, Sinovac Vaccine Only 28% Effective Against ICU Admission - CodeBlue
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Boosting immunity to COVID-19 vaccines | Nature Medicine
